Glenmark to commercialize BeiGene’s oncology drugs in India Sub: Science and tech Sec: Health Tags: Tislelizumab, Zanubrutinib Context: Drugmaker Glenmark has entered into an exclusive marketing and distribution agreement with BeiGene to register and commercialize the latter’s oncology medicines Tislelizumab and Zanubrutinib in India. More on news: Glenmark will be responsible for locally […]